search
Back to results

Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity

Primary Purpose

Obesity

Status
Unknown status
Phase
Phase 4
Locations
China
Study Type
Interventional
Intervention
sildenafil
placebo
Sponsored by
Xiang Guang-da
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity

Eligibility Criteria

20 Years - 30 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • overweight volunteers
  • 20-30 years old
  • body mass index >=25 kg/m2
  • normal glucose tolerance

Exclusion Criteria:

  • normal body mass index
  • abnormal cardiovascular status
  • women
  • history of any local or systemic infectious disease with fever or requiring antibiotic within four weeks of drug administration
  • current addiction to alcohol or substances of abuse
  • children
  • current addiction to alcohol or substances of abuse
  • mental incapacity
  • the use of any medication within four weeks
  • subjects with hyperthyroidism or hypothyroidism, hypertension (even if controlled with medications)

Sites / Locations

  • Wuhan General HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Sildenafil

Placebo group

Arm Description

Eleven patients receive sildenafil 100mg/day (25 mg at 8 AM plus 25 mg at 4 PM plus 50 mg at 10 PM)for 7 days.

An identical placebo for 7 days in placebo group.

Outcomes

Primary Outcome Measures

Browning of white adipose tissue
The browning of white adipose tissue was measured by Western blot (including the expressions of peroxisome proliferator-activated receptor-γ (PPARγ), PPARγcoactivator 1α (PGC-1α), uncoupling protein 1 (UCP-1), the second messenger cyclic guanosine-3', 5'-monophosphate (cGMP),PR domain containing 16 zinc finger transcription factor (Prdm16) and deiodinase, iodothyronine, type II (DIO2)).

Secondary Outcome Measures

Improvement of insulin sensitivity
The insulin sensitivity will be tested by insulin clamp before and after each intervention,respectively.

Full Information

First Posted
August 2, 2015
Last Updated
August 31, 2016
Sponsor
Xiang Guang-da
search

1. Study Identification

Unique Protocol Identification Number
NCT02524184
Brief Title
Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity
Official Title
Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity in Human Adults
Study Type
Interventional

2. Study Status

Record Verification Date
August 2016
Overall Recruitment Status
Unknown status
Study Start Date
August 2015 (undefined)
Primary Completion Date
September 2016 (Anticipated)
Study Completion Date
September 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Xiang Guang-da

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Obesity and metabolic disease result when energy intake consistently exceeds energy expenditure. One appealing new target for treatment is the activation of brown adipose tissue (BAT), an organ recently found to be functional in adult humans. Brown adipocytes selectively express uncoupling protein 1 (UCP1), which renders the inner membrane of mitochondria leaky, thereby diverting chemical energy from ATP generation to heat production. Interest in BAT has been spurred by the recognition that in addition to classical BAT depots, other brown-fat-like cells are present in the subcutaneous white adipose tissue (WAT) in animals and also in humans.These cells have structural and functional properties that resemble brown adipocytes, and they are referred to as beige or 'brite' (brown-in-white) adipocytes. Interestingly, browning of WAT can be induced in animals and humans by physiological stimuli such as cold exposure, which increases adrenergic tone, and by exercise, which selectively drives WAT browning through irisin, an exercise-induced myokine. In addition b-adrenergic drugs and other pharmacological agents,such as prostaglandins, can induce browning of white adipose tissue. More recently, one study showed that treatment of C57BL/6 mice with phosphodiesterase inhibitor sildenafil (12 mg/kg/d) for 7 d caused 4.6-fold increase in uncoupling protein-1 expression and promoted establishment of a brown fat cell-like phenotype ("browning") of WAT in vivo. Therefore, the investigators hypothesized that sildenafil can promote browning of white adipose tissue and improves insulin sensitivity in human adults.
Detailed Description
The study subjects will be taken placebo (first stage) and sildenafil (second stage) intervention for 7 days, respectively afterward.Subcutaneous fat tissue and muscle samples will be obtained by biopsy from some individuals and measure the browning of white adipose tissue and insulin signaling.The insulin sensitivity will be tested by insulin clamp assay before and after each intervention, respectively. In addition,blood samples for biochemical analysis will be obtained before and after each intervention, respectively. The browning of white adipose tissue will be measured by the expressions of peroxisome proliferator-activated receptor-γ (PPARγ), PPARγcoactivator 1α (PGC-1α), uncoupling protein 1 (UCP-1), the second messenger cyclic guanosine-3', 5'-monophosphate (cGMP),PR domain containing 16 zinc finger transcription factor (Prdm16) and deiodinase, iodothyronine, type II (DIO2).The metabolic makers will be measured by blood pressure, heart rate, thyroid functions, resting metabolic rate, respiratory quotient, blood cGMP, blood insulin and blood glucose.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
11 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sildenafil
Arm Type
Experimental
Arm Description
Eleven patients receive sildenafil 100mg/day (25 mg at 8 AM plus 25 mg at 4 PM plus 50 mg at 10 PM)for 7 days.
Arm Title
Placebo group
Arm Type
Placebo Comparator
Arm Description
An identical placebo for 7 days in placebo group.
Intervention Type
Drug
Intervention Name(s)
sildenafil
Intervention Description
sildenafil 100 mg per day for 7 days.
Intervention Type
Drug
Intervention Name(s)
placebo
Intervention Description
an identical placebo per day for 7 days
Primary Outcome Measure Information:
Title
Browning of white adipose tissue
Description
The browning of white adipose tissue was measured by Western blot (including the expressions of peroxisome proliferator-activated receptor-γ (PPARγ), PPARγcoactivator 1α (PGC-1α), uncoupling protein 1 (UCP-1), the second messenger cyclic guanosine-3', 5'-monophosphate (cGMP),PR domain containing 16 zinc finger transcription factor (Prdm16) and deiodinase, iodothyronine, type II (DIO2)).
Time Frame
7 days
Secondary Outcome Measure Information:
Title
Improvement of insulin sensitivity
Description
The insulin sensitivity will be tested by insulin clamp before and after each intervention,respectively.
Time Frame
7days
Other Pre-specified Outcome Measures:
Title
Change of metabolic status
Description
The metabolic status including blood pressure, heart rate, thyroid functions, resting metabolic rate, respiratory quotient, blood cGMP, blood insulin and blood glucose will be measured before and after intervention in each group.
Time Frame
3 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: overweight volunteers 20-30 years old body mass index >=25 kg/m2 normal glucose tolerance Exclusion Criteria: normal body mass index abnormal cardiovascular status women history of any local or systemic infectious disease with fever or requiring antibiotic within four weeks of drug administration current addiction to alcohol or substances of abuse children current addiction to alcohol or substances of abuse mental incapacity the use of any medication within four weeks subjects with hyperthyroidism or hypothyroidism, hypertension (even if controlled with medications)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Guangda Xiang, MD
Phone
086 027 50772191
Email
Guangda64@hotmail.com
Facility Information:
Facility Name
Wuhan General Hospital
City
Wuhan
State/Province
Hubei
ZIP/Postal Code
430070
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guangda Xiang, MD
Phone
13517275283
Email
Guangda64@hotmail.com
First Name & Middle Initial & Last Name & Degree
Lin Xiang, MD
Phone
18627838901
Email
xianglin832010@hotmail.com

12. IPD Sharing Statement

Citations:
PubMed Identifier
28986166
Citation
Li S, Li Y, Xiang L, Dong J, Liu M, Xiang G. Sildenafil induces browning of subcutaneous white adipose tissue in overweight adults. Metabolism. 2018 Jan;78:106-117. doi: 10.1016/j.metabol.2017.09.008. Epub 2017 Oct 3.
Results Reference
derived

Learn more about this trial

Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity

We'll reach out to this number within 24 hrs